Last Posted: Sep 04, 2020
- ‘CRISPR babies’ are still too risky, says influential panel - The safety and efficacy of gene editing human embryos hasn’t been proven, researchers warn.
H Ledford Nature News, September 4, 2020 - International Commission on the Clinical Use of Human Germline Genome Editing - Report Release Webinar
Sep 3, 2020 - 10:15AM - 11:15AM ET - CRISPR/Cas9-mediated gene correction in hemophilia B patient-derived iPSCs.
Morishige Satoshi et al. International journal of hematology 2020 Feb 111(2) 225-233 - The Evolution of Gene Therapy in the Treatment of Metabolic Liver Diseases.
Moscoso Carlos G et al. Genes 2020 Aug 11(8) - Does human genome editing reinforce or violate human dignity?
Segers Seppe et al. Bioethics 2020 34(1) 33-40 - Germline genome editing versus preimplantation genetic diagnosis: Is there a case in favour of germline interventions?
Ranisch Robert et al. Bioethics 2020 34(1) 60-69 - Comments on the CRISPR Gene-edited babies' case.
Cong Yali et al. Indian journal of medical ethics 4 (NS)(4) 297-300 - Estimating Demand for Germline Genome Editing: An In Vitro Fertilization Clinic Perspective.
Viotti Manuel et al. The CRISPR journal 2019 2(5) 304-315 - The Use and Misuse of Brave New World in the CRISPR Debate.
So Derek et al. The CRISPR journal 2019 2(5) 316-323 - THE GORDON WILSON LECTURE: THE ETHICS OF HUMAN GENOME EDITING.
Coller Barry S et al. Transactions of the American Clinical and Climatological Association 2020 13199-118
.png)
No hay comentarios:
Publicar un comentario